The journey from early-phase clinical trials to successful commercial launch for an injectable drug product is complex and multifaceted. Choosing between a traditional vial or prefilled syringe and a modern autoinjector can significantly impact patient experience, adherence, and market competitiveness when considering the delivery system. In this article published by ONdrugDelivery, Jeff Clement and William Welch from PCI Pharma Services explore the emergence of parallel development as a strategic approach to expedite the development process and bring innovative therapies in drug devices such as autoinjectors to market faster. Providing insight in navigating key considerations such as drug product device compatibility, manufacturability and packaging design to allow biopharmaceutical companies to proactively and strategically streamline their clinical to commercial process and ultimately improve patient outcomes. https://lnkd.in/gA2uz2vR #PatientCentricity #AutoInjectors #CDMO #LetsTalkFuture
PCI Pharma Services’ Post
More Relevant Posts
-
Biopharmaceutical and medtech companies are facing a number of growing challenges with pressure to increase inventory turns, improve margins, strengthen brand and grow revenue. We believe that a patient-centric approach to quality can have a significant and positive impact on achieving these goals. And it’s no surprise that 91% of participants across industries and functions also consider having a patient-centric quality approach to be a strategic advantage for their organisation. To find out where the industry stands on ‘patient-centred quality’, we surveyed and assessed the current approach to quality of biopharma and medical device companies. #Pharma #Biopharma #Medtech https://lnkd.in/e6g9vzF8
To view or add a comment, sign in
-
With innovative therapies transforming patients' lives worldwide every day, biopharmaceutical companies face the challenge of developing and delivering these products in a dynamic, ever-changing market. Inflationary market conditions and funding pressures mean speed-to-patient and efficiency are more critical than ever. New technologies and processes are helping to address these needs by accelerating sterile manufacturing while improving efficiency, reducing costs, and increasing drug product quality, all while delivering sterility assurance. PCI Pharma Services robotic gloveless isolator processing is gaining popularity for the primary filling of Ready-to-Use (RTU) containers. Utilizing the latest advancements in robotic sterile filling technologies provides flexible aseptic fill-finish solutions to supply life-changing therapies to patients safely and efficiently. Read more in the latest article, 'Meeting accelerated early phase clinical timelines for small and emerging biopharma,' published in Samedan Ltd International Clinical Trials (ICT) here: https://lnkd.in/emvp2_TD #SterileFillFinish #BioTech #CDMO #LetsTalkFuture
To view or add a comment, sign in
-
Partner at PwC LLP in Risk, lead partner for NHS National Bodies and PwC UK Supervisory board member
91% of respondents to our Global Quality Survey see a patient-centred approach to quality as a strategic advantage for their company. But 76% of survey participants don’t believe that their organisation has yet reached the quality maturity it should have. Our latest survey explores how biopharmaceutical and medtech companies approach quality today and shows how quality organisations can embrace a patient-centric approach to drive value. Find out more. https://lnkd.in/e6gfwWNj #Pharma #Biopharma #Medtech
Putting patients at the centre of quality
pwc.ch
To view or add a comment, sign in
-
How can quality organisations embrace a patient-centric approach to drive value? To find out where the industry stands on ‘patient-centred quality’, we surveyed and assessed biopharmaceutical and medtech companies’ current approach to #quality. Find out about the findings of the survey and our framework that aims to help quality organisations on their journey towards patient-centred quality in our latest publication Putting patients at the centre of quality. #Pharma #Biopharma #Medtech https://lnkd.in/e3fcdvcg
Putting patients at the centre of quality
pwc.ch
To view or add a comment, sign in
-
How can quality organisations embrace a patient-centric approach to drive value? To find out where the industry stands on ‘patient-centred quality’, we surveyed and assessed biopharmaceutical and medtech companies’ current approach to #quality. Find out about the findings of the survey and our framework that aims to help quality organisations on their journey towards patient-centred quality in our latest publication Putting patients at the centre of quality. #Pharma #Biopharma #Medtech https://lnkd.in/et2B4MpQ
Putting patients at the centre of quality
pwc.ch
To view or add a comment, sign in
-
How can quality organisations embrace a patient-centric approach to drive value? To find out where the industry stands on ‘patient-centred quality’, we surveyed and assessed biopharmaceutical and medtech companies’ current approach to #quality. Find out about the findings of the survey and our framework that aims to help quality organisations on their journey towards patient-centred quality in our latest publication Putting patients at the centre of quality. #Pharma #Biopharma #Medtech https://lnkd.in/ep3Y37VJ
Putting patients at the centre of quality
pwc.ch
To view or add a comment, sign in
-
Problem solving executive obsessed with supporting healthcare system & pharmaceutical clients in overcoming business challenges and meeting strategic goals. Father, sailor, skier and animal lover.
Biopharmaceutical and medtech companies are facing a number of growing challenges with pressure to increase inventory turns, improve margins, strengthen brand and grow revenue. We believe that a patient-centric approach to quality can have a significant and positive impact on achieving these goals. And it’s no surprise that 91% of participants across industries and functions also consider having a patient-centric quality approach to be a strategic advantage for their organisation. To find out where the industry stands on ‘patient-centred quality’, we surveyed and assessed the current approach to quality of biopharma and medical device companies. #Pharma #Biopharma #Medtech https://lnkd.in/eXdMED6Q
Putting patients at the centre of quality
pwc.ch
To view or add a comment, sign in
-
Problem solving executive obsessed with supporting healthcare system & pharmaceutical clients in overcoming business challenges and meeting strategic goals. Father, sailor, skier and animal lover.
We believe that a patient-centric approach to quality in biopharmaceutical and medtech companies can have a significant and positive impact on addressing the industry’s current challenges. In fact, 91% of those surveyed in our Global Quality Survey also think that a patient-centric quality approach creates a strategic advantage for their organisation. Our latest survey explores how organisations approach quality today and identifies opportunities to improve and enhance patient and business outcomes through quality. #Pharma #Biopharma #Medtech https://lnkd.in/eXdMED6Q
Putting patients at the centre of quality
pwc.ch
To view or add a comment, sign in
-
Pearl Pathways, part of Versiti Clinical Trials, is dedicated to supporting biopharmaceutical, medical device and diagnostic companies, as well as life science service providers with their clinical, regulatory and quality compliance needs. Connect with Pearl Pathways to learn more about how they can assist your clinical trial in navigating the complexities of the industry. Discover Pearl Pathways: https://bit.ly/3Qhf7VV #LifeSciences #Biopharmaceutical #MedicalDevices #Diagnostics #RegulatoryCompliance #ClinicalSupport #QualityAssurance #HealthcareIndustry #BioTech #MedTech #LifeScienceServices #PearlPathways #HealthcareConsulting #RegulatoryAffairs #ClinicalTrials #QualityCompliance #Innovation #HealthcareSolutions #FDACompliance #HealthcareRegulations
To view or add a comment, sign in
-
The pharmaceutical industry continuously struggles with supply chain issues due to globalization, climate change, and an aging world population. Supply chain disruptions cause drug shortages and consequently impact healthcare systems worldwide. The pharmaceutical industry would benefit from manufacturing innovation and adoption of advanced technologies such as pharmaceutical continuous manufacturing (PCM) to address patient need's. At the upcoming PCM Business Summit by Pharmatech Associates, a USP company, we will showcase how to address these issues within a single initiative. Contact me for further information. #orphandrugs #oncology #CDMO #CRDMO #continuousmanufacturing #advancedtechnology #pharma4.0 #drugshortage #supplychain
To view or add a comment, sign in
54,386 followers
More from this author
-
Rachel Griffiths & Craig LaMarca discuss the growing demand for speed to clinic and market and the significance of partnering with the right CDMO.
PCI Pharma Services 1d -
Building Robust Supply Chains to Prevent Drug Shortages
PCI Pharma Services 4mo -
Navigating the Complex Landscape of Drug-Device Combination Products
PCI Pharma Services 5mo